These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 7527173)
1. Complementation of human immunodeficiency virus type 1 vif mutants in some CD4+ T-cell lines. Hevey M; Donehower LA Virus Res; 1994 Sep; 33(3):269-80. PubMed ID: 7527173 [TBL] [Abstract][Full Text] [Related]
2. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189 [TBL] [Abstract][Full Text] [Related]
3. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus. Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392 [TBL] [Abstract][Full Text] [Related]
4. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants. Reddy TR; Kraus G; Yamada O; Looney DJ; Suhasini M; Wong-Staal F J Virol; 1995 Jun; 69(6):3549-53. PubMed ID: 7745702 [TBL] [Abstract][Full Text] [Related]
5. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. Gabuzda DH; Li H; Lawrence K; Vasir BS; Crawford K; Langhoff E J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):908-15. PubMed ID: 7519673 [TBL] [Abstract][Full Text] [Related]
6. Cell-free transmission of Vif mutants of HIV-1. Fan L; Peden K Virology; 1992 Sep; 190(1):19-29. PubMed ID: 1529528 [TBL] [Abstract][Full Text] [Related]
7. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. Michaels FH; Hattori N; Gallo RC; Franchini G AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants. Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289 [TBL] [Abstract][Full Text] [Related]
9. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus. Park IW; Myrick K; Sodroski J J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1228-36. PubMed ID: 7965633 [TBL] [Abstract][Full Text] [Related]
10. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. Madani N; Kabat D J Virol; 1998 Dec; 72(12):10251-5. PubMed ID: 9811770 [TBL] [Abstract][Full Text] [Related]
11. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis. Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851 [TBL] [Abstract][Full Text] [Related]
13. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943 [TBL] [Abstract][Full Text] [Related]
14. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. Chowdhury IH; Chao W; Potash MJ; Sova P; Gendelman HE; Volsky DJ J Virol; 1996 Aug; 70(8):5336-45. PubMed ID: 8764044 [TBL] [Abstract][Full Text] [Related]
15. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. Sova P; Volsky DJ J Virol; 1993 Oct; 67(10):6322-6. PubMed ID: 8371360 [TBL] [Abstract][Full Text] [Related]
16. Apparent lack of trans-dominant negative effects of various vif mutants on the replication of HIV-1. Fujita M; Matsumoto S; Sakurai A; Doi N; Miyaura M; Yoshida A; Adachi A Microbes Infect; 2002 Oct; 4(12):1203-7. PubMed ID: 12467760 [TBL] [Abstract][Full Text] [Related]
17. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization. Nagashunmugam T; Friedman HM DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209 [TBL] [Abstract][Full Text] [Related]
18. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385 [TBL] [Abstract][Full Text] [Related]
19. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors. Simm M; Pekarskaya O; Potash MJ; Volsky DJ AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355 [TBL] [Abstract][Full Text] [Related]
20. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. Sakai K; Ma XY; Gordienko I; Volsky DJ J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]